Your browser doesn't support javascript.
loading
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d'arrhythmies cardiaques)-group.
Müller-Edenborn, Björn; Moreno-Weidmann, Zoraida; Venier, Sandrine; Defaye, Pascale; Park, Chan-Il; Guerra, José; Alonso-Martín, Concepcion; Bazan, Victor; Vinolas, Xavier; Rodriguez-Font, Enrique; Garcia, Bieito Campos; Boveda, Serge; Combes, Stéphane; Albenque, Jean-Paul; Guy-Moyat, Benoit; Trenk, Dietmar; Eichenlaub, Martin; Chen, Juan; Lehrmann, Heiko; Neumann, Franz-Josef; Arentz, Thomas; Jadidi, Amir.
Afiliación
  • Müller-Edenborn B; Department of Cardiology and Angiology II, Section for Electrophysiology, Heart Center, University of Freiburg, Südring 15, 79189, Bad Krozingen, Germany. bjoern.mueller-edenborn@universitaets-herzzentrum.de.
  • Moreno-Weidmann Z; Department of Cardiology, Julius-Hospital, Würzburg, Germany. bjoern.mueller-edenborn@universitaets-herzzentrum.de.
  • Venier S; Department of Cardiology and Angiology II, Section for Electrophysiology, Heart Center, University of Freiburg, Südring 15, 79189, Bad Krozingen, Germany.
  • Defaye P; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Park CI; Department of Cardiology, University Hospital Grenoble, Grenoble, France.
  • Guerra J; Department of Cardiology, University Hospital Grenoble, Grenoble, France.
  • Alonso-Martín C; Department of Cardiology, Clinique de la Tour, Geneva, Switzerland.
  • Bazan V; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Vinolas X; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Rodriguez-Font E; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Garcia BC; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Boveda S; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Combes S; Department of Electrophysiology, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
  • Albenque JP; Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.
  • Guy-Moyat B; Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.
  • Trenk D; Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.
  • Eichenlaub M; Department of Cardiology, University Hospital Limoges, Limoges, France.
  • Chen J; Department of Cardiology and Angiology II, Section for Pharmacology, Heart Center, University of Freiburg, Bad Krozingen, Germany.
  • Lehrmann H; Department of Cardiology and Angiology II, Section for Electrophysiology, Heart Center, University of Freiburg, Südring 15, 79189, Bad Krozingen, Germany.
  • Neumann FJ; Department of Electrophysiology, University Hospital Mainz, Mainz, Germany.
  • Arentz T; Department of Cardiology and Angiology II, Section for Electrophysiology, Heart Center, University of Freiburg, Südring 15, 79189, Bad Krozingen, Germany.
  • Jadidi A; Department of Cardiology and Angiology II, Heart Center, University of Freiburg, Bad Krozingen, Germany.
Clin Res Cardiol ; 111(9): 1018-1027, 2022 Sep.
Article en En | MEDLINE | ID: mdl-34854991
ABSTRACT

AIMS:

Despite advances in interventional treatment strategies, atrial fibrillation (AF) remains associated with significant morbidity and mortality. Fibrotic atrial myopathy (FAM) is a main factor for adverse outcomes of AF-ablation, but complex to diagnose using current methods. We aimed to derive a scoring system based entirely on easily available clinical parameters to predict FAM and ablation-success in everyday care.

METHODS:

In this multicenter, prospective study, a new risk stratification model termed AF-SCORE was derived in 220 patients undergoing high-density left-atrial(LA) voltage-mapping to quantify FAM. AF-SCORE was validated for FAM in an external mapping-validation cohort (n = 220) and for success following pulmonary vein isolation (PVI)-only (without adjunctive left- or right atrial ablations) in an external outcome-validation cohort (n = 518).

RESULTS:

FAM was rare in patients < 60 years (5.4%), but increased with ageing and affected 40.4% (59/146) of patients ≥ 60 years. Sex and AF-phenotype had additional predictive value in older patients and remained associated with FAM in multivariate models (odds ratio [OR] 6.194, p < 0.0001 for ≥ 60 years; OR 2.863, p < 0.0001 for female sex; OR 41.309, p < 0.0001 for AF-persistency). Additional clinical or diagnostic variables did not improve the model. AF-SCORE (+ 1 point for age ≥ 60 years and additional points for female sex [+ 1] and AF-persistency [+ 2]) showed good discrimination to detect FAM (c-statistic 0.792) and predicted arrhythmia-freedom following PVI (74.3%, 54.7% and 45.5% for AF-SCORE ≤ 2, 3 and 4, respectively, and hazard ratio [HR] 1.994 for AF-SCORE = 3 and HR 2.866 for AF-SCORE = 4, p < 0.001).

CONCLUSIONS:

Age, sex and AF-phenotype are the main determinants for the development of FAM. A low AF-SCORE ≤ 2 is found in paroxysmal AF-patients of any age and younger patients with persistent AF irrespective of sex, and associated with favorable outcomes of PVI-only. Freedom from arrhythmia remains unsatisfactory with AF-SCORE ≥ 3 as found in older patients, particularly females, with persistent AF, and future studies investigating adjunctive atrial ablations to PVI-only should focus on these groups of patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter / Cardiomiopatías Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter / Cardiomiopatías Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania